248 related articles for article (PubMed ID: 16469486)
21. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia.
Handrup MM; Møller JK; Frydenberg M; Schrøder H
Pediatr Blood Cancer; 2010 Aug; 55(2):309-13. PubMed ID: 20582964
[TBL] [Abstract][Full Text] [Related]
22. Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device.
Biffi R; Martinelli G; Pozzi S; Cinieri S; Cocorocchio E; Peccatori F; Ferrucci PF; Pistorio R; Andreoni B
Bone Marrow Transplant; 1999 Jul; 24(1):89-93. PubMed ID: 10435741
[TBL] [Abstract][Full Text] [Related]
23. Overview of the use of implantable venous access devices in the management of children with inherited bleeding disorders.
Komvilaisak P; Connolly B; Naqvi A; Blanchette V
Haemophilia; 2006 Dec; 12 Suppl 6():87-93. PubMed ID: 17123400
[TBL] [Abstract][Full Text] [Related]
24. Totally implantable venous access port systems and risk factors for complications: a one-year prospective study in a cancer centre.
Narducci F; Jean-Laurent M; Boulanger L; El Bédoui S; Mallet Y; Houpeau JL; Hamdani A; Penel N; Fournier C
Eur J Surg Oncol; 2011 Oct; 37(10):913-8. PubMed ID: 21831566
[TBL] [Abstract][Full Text] [Related]
25. Totally implantable central venous access devices in children with hemato-oncologic malignancies: evaluation of complications and comparison of incidence of febrile episodes with similar patients without central venous access devices.
Sarper N; Zengin E; Corapçioglu F; Tugay M
Pediatr Hematol Oncol; 2006 Sep; 23(6):459-70. PubMed ID: 16849276
[TBL] [Abstract][Full Text] [Related]
26. How long does it take to "rule out" bacteremia in children with central venous catheters?
Shah SS; Downes KJ; Elliott MR; Bell LM; McGowan KL; Metlay JP
Pediatrics; 2008 Jan; 121(1):135-41. PubMed ID: 18166567
[TBL] [Abstract][Full Text] [Related]
27. Totally implantable central venous access ports for long-term chemotherapy. A prospective study analyzing complications and costs of 333 devices with a minimum follow-up of 180 days.
Biffi R; de Braud F; Orsi F; Pozzi S; Mauri S; Goldhirsch A; Nolè F; Andreoni B
Ann Oncol; 1998 Jul; 9(7):767-73. PubMed ID: 9739444
[TBL] [Abstract][Full Text] [Related]
28. [Percutaneous implant of Hickman catheters and reservoirs. Long-term experience].
Carreira Villamor JM; Reyes Pérez R; Pulido-Duque JM; Gorriz Gómez E; Pardo MD; Argiles Vives JM; Eyheremendy EP; Maynar Moliner M
Rev Clin Esp; 1997 Nov; 197(11):740-4. PubMed ID: 9547192
[TBL] [Abstract][Full Text] [Related]
29. Peripheral infusion ports for central venous access in patients with gynecologic malignancies.
Cunningham MJ; Collins MB; Kredentser DC; Malfetano JH
Gynecol Oncol; 1996 Mar; 60(3):397-9. PubMed ID: 8774645
[TBL] [Abstract][Full Text] [Related]
30. Subcutaneously implanted central venous access device infection in pediatric patients with cancer.
Hung MC; Chen CJ; Wu KG; Hung GY; Lin YJ; Tang RB
J Microbiol Immunol Infect; 2009 Apr; 42(2):166-71. PubMed ID: 19597650
[TBL] [Abstract][Full Text] [Related]
31. Use of totally implantable catheters for peripheral blood stem cell apheresis.
Carausu L; Clapisson G; Philip I; Sebban H; Marec-Bérard P
Bone Marrow Transplant; 2007 Sep; 40(5):417-22. PubMed ID: 17603515
[TBL] [Abstract][Full Text] [Related]
32. Management of end-stage central venous access in children referred for possible small bowel transplantation.
Rodrigues AF; van Mourik ID; Sharif K; Barron DJ; de Giovanni JV; Bennett J; Bromley P; Protheroe S; John P; de Ville de Goyet J; Beath SV
J Pediatr Gastroenterol Nutr; 2006 Apr; 42(4):427-33. PubMed ID: 16641582
[TBL] [Abstract][Full Text] [Related]
33. Factors influencing central line infections in children with acute lymphoblastic leukemia: results of a single institutional study.
Abbas AA; Fryer CJ; Paltiel C; Chedid F; Felimban SK; Yousef AA; Khattab TM
Pediatr Blood Cancer; 2004 Apr; 42(4):325-31. PubMed ID: 14966828
[TBL] [Abstract][Full Text] [Related]
34. Totally implantable venous access ports: retrospective review of long-term complications in 81 patients.
Bassi KK; Giri AK; Pattanayak M; Abraham SW; Pandey KK
Indian J Cancer; 2012; 49(1):114-8. PubMed ID: 22842178
[TBL] [Abstract][Full Text] [Related]
35. Factors influencing catheter-related infections in the Dutch multicenter study on high-dose chemotherapy followed by peripheral SCT in high-risk breast cancer patients.
Nieboer P; de Vries EG; Mulder NH; Rodenhuis S; Bontenbal M; van der Wall E; van Hoesel QG; Smit WM; Hupperets P; Voest EE; Nooij MA; Boezen HM; van der Graaf WT
Bone Marrow Transplant; 2008 Oct; 42(7):475-81. PubMed ID: 18622420
[TBL] [Abstract][Full Text] [Related]
36. The catheter is stuck: complications experienced during removal of a totally implantable venous access device. A single-center study in 200 children.
Wilson GJ; van Noesel MM; Hop WC; van de Ven C
J Pediatr Surg; 2006 Oct; 41(10):1694-8. PubMed ID: 17011271
[TBL] [Abstract][Full Text] [Related]
37. Central venous access ports in children treated for hematopoietic malignancies.
Bucki B; Tomaszewska R; Karpe J; Stoksik P; Sońta-Jakimczyk D; Szczepański T
Pediatr Hematol Oncol; 2008 Dec; 25(8):751-5. PubMed ID: 19065441
[TBL] [Abstract][Full Text] [Related]
38. Mechanical complications related to indwelling central venous catheter in pediatric hematology/oncology patients.
Fratino G; Mazzola C; Buffa P; Torre M; Castagnola E; Magillo P; Molinari AC
Pediatr Hematol Oncol; 2001; 18(5):317-24. PubMed ID: 11452403
[TBL] [Abstract][Full Text] [Related]
39. Feasibility of prophylaxis and immune tolerance induction regimens in haemophilic children using fully implantable central venous catheters.
Mancuso ME; Mannucci PM; Sartori A; Agliardi A; Santagostino E
Br J Haematol; 2008 May; 141(5):689-95. PubMed ID: 18410458
[TBL] [Abstract][Full Text] [Related]
40. [Sepsis in children using venous implants with reservoir].
Muguerza R; Gutiérrez JM; Gámez M; de Agustín JC; Murcia J; Utrilla JG
Cir Pediatr; 1991 Jan; 4(1):19-22. PubMed ID: 2043429
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
